Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Short-Term Debt issuances (2024 - 2025)

Nuvation Bio (NUVB) has disclosed Short-Term Debt issuances for 2 consecutive years, with $11.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Short-Term Debt issuances rose 100.95% to $11.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $16.8 million, a 200.95% increase, with the full-year FY2025 number at $60.1 million, up 376.66% from a year prior.
  • Short-Term Debt issuances was $11.2 million for Q4 2025 at Nuvation Bio, up from $5.6 million in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $11.2 million in Q4 2025 to a low of $5.6 million in Q4 2024.